Serotonin Receptors in Plain Language: What 5-HT2A Does and Does Not Explain

Serotonin and its receptors

Serotonin is a chemical messenger in the brain. The US National Institute on Drug Abuse (NIDA) says it plays an important role in regulating mood, sleep, pain and appetite. [1] Messengers act on cells by fitting into receptors, which are molecular structures on or in the cell. There are several kinds of serotonin receptor. The one most often discussed for classic psychedelics is called 5-HT2A (5-hydroxytryptamine 2A).

What 5-HT2A is reported to explain

• The group definition. NIDA says classic psychedelics such as psilocybin and LSD mainly interact with 5-HT2A receptors. [2] A 2016 pharmacology review reports a consensus that psychedelics are agonists or partial agonists at these receptors, with particular importance for those on certain cortical nerve cells. [3] (An agonist switches a receptor on, fully or partly.)
• Some effects in people. In a human study of psilocybin, a drug that blocks 5-HT2A receptors prevented changes in visual brain responses linked to visual effects. The researchers concluded that 5-HT2A activation underlies those effects. [4] This is one measured effect in one controlled study, not a full account of the experience.
• Mescaline. A review says mescaline's main hallucinogenic effects are mediated through its action at 5-HT2A receptors. [5]
• Regulatory language. The FDA's 2026 guidance describes classic psychedelics as typically understood to be 5-HT2A receptor agonists. [6]

What 5-HT2A does not explain

One receptor is not the whole story. Several sources describe wider actions even for classic psychedelics:

• Mescaline is reported to act at 5-HT2A and 5-HT2C receptors and also at noradrenaline and dopamine receptors. [5]
• Psilocybin is described as a non-selective agonist at many serotonin receptors, especially 5-HT2A. [7]
• DMT is described as a 5-HT1A/2A partial agonist. [8]

Therapeutic benefit. A 2026 review says that although 5-HT2A activation is critical for psychedelics' psychopharmacological effects, the precise signaling pathways are still under investigation and it is uncertain which signaling mechanisms are necessary for rapid-acting and durable therapeutic effects. [9] A review on psilocybin and depression says the mechanisms behind its antidepressant and psychedelic effects are currently unknown. [7] The evidence label for "5-HT2A explains the benefit" is therefore insufficient evidence. See Proposed Mechanisms vs Proven Clinical Outcomes.

Not all psychoactive substances use this system

Never assume that every psychoactive substance acts through serotonin 5-HT2A receptors. Sources describe different main systems.

This is why Dissociatives, Entactogens and Other Hallucinogenic Substances each have their own page, and why Why Different Substances Cannot Be Treated as Equivalent matters.

How to read a headline about "the receptor"

• A receptor finding is a mechanism finding. It does not show benefit or safety in people.
• Results in cells or animals are preclinical and are not treated here as results in people.
• Naming the receptor does not tell you the amount, product or setting that was studied.

Education only

This page explains receptors in plain language. It gives no amounts, no sourcing advice and no advice to use anything. If you take medicines that affect serotonin, speak with a prescriber or pharmacist before anything else that does; see Serotonergic Medicines and Substance-Specific Evidence.